Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2004-04-07
2009-08-11
Shiao, Rei-Tsang (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S237800, C514S252120, C514S317000, C514S365000, C514S374000, C514S396000, C514S408000, C514S602000, C514S616000, C544S059000, C544S162000, C544S399000, C546S229000, C548S577000, C564S086000, C564S152000
Reexamination Certificate
active
07572790
ABSTRACT:
Compound of formula (I):or pharmaceutically acceptable derivatives thereof, and their use as pharmaceuticals, particularly as p38 kinase inhibitors.
REFERENCES:
patent: 4200750 (1980-04-01), Warner et al.
patent: 5236934 (1993-08-01), VanAtten
patent: 5246943 (1993-09-01), Blankley et al.
patent: 5521213 (1996-05-01), Prasit et al.
patent: 5534518 (1996-07-01), Henrie et al.
patent: 5658903 (1997-08-01), Adams et al.
patent: 5858995 (1999-01-01), Kawai et al.
patent: 5932576 (1999-08-01), Anantanarayan et al.
patent: 5945418 (1999-08-01), Bemis et al.
patent: 5977103 (1999-11-01), Adams et al.
patent: 6087496 (2000-07-01), Anantanarayan et al.
patent: 6130235 (2000-10-01), Mavunkel et al.
patent: 6147080 (2000-11-01), Bemis et al.
patent: 6174887 (2001-01-01), Haruta et al.
patent: 6251914 (2001-06-01), Adams et al.
patent: 6277989 (2001-08-01), Chakravarty et al.
patent: 6436925 (2002-08-01), Lubisch et al.
patent: 6451794 (2002-09-01), Beswick et al.
patent: 6498166 (2002-12-01), Campbell et al.
patent: 6509361 (2003-01-01), Weier et al.
patent: 6509363 (2003-01-01), Salituro et al.
patent: 6579872 (2003-06-01), Brown et al.
patent: 6638980 (2003-10-01), Su et al.
patent: 6696464 (2004-02-01), McClure et al.
patent: 6774127 (2004-08-01), Adams et al.
patent: 6821965 (2004-11-01), Brown et al.
patent: 6855719 (2005-02-01), Thomas et al.
patent: 7056942 (2006-06-01), Hildesheim et al.
patent: 2001/0011135 (2001-08-01), Reidl et al.
patent: 2004/0038858 (2004-02-01), Dorsch et al.
patent: 2004/0176446 (2004-09-01), Alonso-Alija et al.
patent: 2004/0242868 (2004-12-01), Angell et al.
patent: 2004/0249161 (2004-12-01), Angell et al.
patent: 2004/0266839 (2004-12-01), Angell et al.
patent: 2004/0267012 (2004-12-01), Angell et al.
patent: 2005/0020540 (2005-01-01), Angell et al.
patent: 2005/0020590 (2005-01-01), Lang et al.
patent: 2005/0038014 (2005-02-01), Angell et al.
patent: 2005/0065195 (2005-03-01), Angell et al.
patent: 2005/0090491 (2005-04-01), Angell et al.
patent: 0 533 266 (1992-09-01), None
patent: 0 533 268 (1992-09-01), None
patent: 0 346 841 (2003-06-01), None
patent: 0 430 033 (2004-04-01), None
patent: 2 276 161 (1993-03-01), None
patent: 2 276 162 (1993-03-01), None
patent: 2 273 930 (1993-12-01), None
patent: 2 295 387 (1996-05-01), None
patent: WO 94/15920 (1994-07-01), None
patent: WO 95/06636 (1995-03-01), None
patent: WO 95/06644 (1995-03-01), None
patent: WO 95/11243 (1995-04-01), None
patent: WO 95/15954 (1995-06-01), None
patent: WO 95/17401 (1995-06-01), None
patent: WO 95/29907 (1995-11-01), None
patent: WO 95/30675 (1995-11-01), None
patent: WO 96/31508 (1996-10-01), None
patent: WO 96/31509 (1996-10-01), None
patent: WO 97/03034 (1997-01-01), None
patent: WO 99/32463 (1999-07-01), None
patent: WO 00/12074 (2000-03-01), None
patent: WO 00/12497 (2000-03-01), None
patent: WO 00/26216 (2000-05-01), None
patent: WO 00/56738 (2000-09-01), None
patent: WO 00/71493 (2000-11-01), None
patent: WO 00/71509 (2000-11-01), None
patent: WO 00/71510 (2000-11-01), None
patent: WO 00/71511 (2000-11-01), None
patent: WO 01/27089 (2001-04-01), None
patent: WO 01/34605 (2001-05-01), None
patent: WO 01/70695 (2001-09-01), None
patent: WO 01/87875 (2001-11-01), None
patent: WO 02/09648 (2002-02-01), None
patent: WO 02/40486 (2002-05-01), None
patent: WO 03/032970 (2003-04-01), None
patent: WO 03/068747 (2003-08-01), None
patent: WO 03/093248 (2003-11-01), None
patent: WO 2004/010995 (2004-02-01), None
patent: WO 2004/089875 (2004-10-01), None
patent: WO 2004/089876 (2004-10-01), None
patent: WO 2005/014550 (2005-02-01), None
patent: WO 2005/061465 (2005-07-01), None
Salituro et al. “Inhibitors of p38 MAP Kinase: Therapeutic Intervention in Cytokine-Mediated Diseases” Current Medicinal Chemistry, 1999, vol. 6, pp. 807-823.
Boehm et al.,Expert Opinion of Therapeutic Patents, vol. 10 (1) pp. 25-37 (2000).
Boehm, et al,Journal of Medicinal Chemistry, vol. 39(20) pp. 3929-3937 (1996).
Ceccarelli et al.,European Journal of Medicinal Chemistry, vol. 33 (12) pp. 943-955 (1998).
Gabriele et al.,European Journal of Organic Chemistry, vol. 2001 (24) pp. 4607-4613 (2001).
Han et al.,Biohemica et Biophysica Acta—Molecular Cell Research, vol. 1265 (2-3) pp. 224-227 (1995.
Hanson,Expert Opinion on Therapeutic Patents, vol. 7(7) pp. 729-733 (1997).
Henry et al.,Drugs of the Future, vol. 24 (12) pp. 1345-1354 (1999).
Jiang et al,Journal of Biological Chemistry, vol. 271 (30) pp. 17920-17926 (1996).
Li et al.,Biochemical and Biophysical Research Communications, vol. 228 (2) pp. 334-340 (1996).
Liebeskind et al.,Organic Letters, vol. 4 (6) pp. 979-981 (2002).
Moreland et al.,Annals of Internal Medicine, vol. 130 (6) pp. 478-486 (1999).
Murali Dhar et al.,Bioorganic and Medicinal Chemistry Letters, vol. 12 (21) pp. 3125-3128 (2002).
Rankin et al.,British Journal of Rheumatology, vol. 34 pp. 334-342 (1995).
Salituro et al.,Current Medicinal Chemistry, vol. 6 pp. 807-823 (1999).
Wang et al.,Journal of Biological Chemistry, vol. 272 (38) pp. 23668-23674 (1997).
Aston Nicola Mary
Bamborough Paul
Jones Katherine Louise
Patel Vipulkumar Kantibhai
Swanson Stephen
Dinner Dara L.
Kinzig Charles M.
Kosack Joseph R
Shiao Rei-Tsang
SmithKline Beecham Corporation
LandOfFree
Biphenyl carboxylic amide p38 kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Biphenyl carboxylic amide p38 kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biphenyl carboxylic amide p38 kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4134745